A bot that can detect chemical cues that signal the presence of cancer cells in a tissue and then do something about it is being hailed as a game changer.
The bot, developed by scientists at Stanford University and MIT, was described as a “very powerful tool” by a panel of experts on Friday at the Society for Neuroscience’s annual conference in San Francisco.
The team is also working on an alternative version of the bot, which would be a better fit for patients with severe disease and who are not at a higher risk for developing cancer, said Dr. Mark S. Zimring, the Stanford neuroscientist who led the research.
The bot is also different from other “self-preservation” robots.
It uses the signals of cancerous cells to identify where to implant a pacemaker, or a heart valve, or other medical device.
These signals can be sent directly to the patient.
But because it’s a machine, it can’t do that.
Instead, it sends the signal to an artificial brain that uses a computer to learn what the patient is looking for.
“We can detect whether the signal is benign or not, and then use that information to decide whether to implant the pacemaker or the valve or whatever,” said Dr, Jonathan Bowers, an assistant professor of biomedical engineering at MIT.
“So the robot can actually make these decisions about whether to use the machine or not.”
Researchers have been working on robots with more advanced algorithms to help doctors perform more complicated tasks.
But the team’s bot is a “greater precision” version of what doctors can do on their own, Zimrings said.
The researchers have already tested it in trials in animals.
They’ve also been testing it in human patients.
In one study, doctors implanted a pacemaker in a patient who was being treated for cancer.
The patient was also using the bot to do things like check on a patient’s condition and take measurements.
The AI team at Stanford and MIT is working with a number of different companies to build a similar bot.
In the first phase of the project, the researchers were able to test a bot that could detect cancerous growths in skin cells and detect them before they went into the blood stream.
It’s also being used to identify abnormal changes in the brain in the face of brain tumors.
The scientists are now working on a second phase of testing the bot in a more human-like environment.
That study has shown the bot is able to do a more complex task than any other bot currently on the market.
For example, it could recognize that a tumor was present in a part of the brain and determine whether to remove the tumor or not.
But that was only a first step.
The team is now working to develop a way to detect when cancer cells are growing in the bloodstream.
The scientists have also been developing an AI bot that has been shown to be able to detect tumor-causing bacteria in the human gut.
The researchers say that AI can now be used to help diagnose cancer early in the disease process, and to diagnose certain types of tumors more accurately.
That will likely lead to more accurate diagnosis, Zimbring said.
Researchers are also working with the University of Texas Medical Branch to build an AI-based system that could be used in the diagnostics of breast cancer.
This could mean that doctors could diagnose breast cancer by looking for changes in a tumor in the breast tissue.
The development of an AI system is important, because the team is hoping to build robots that can perform more complex tasks, such as checking a patient for a blood clot or finding abnormal changes to blood vessels in a person.